BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
+$1.69B |
| 2 |
Apple
AAPL
|
+$892M |
| 3 |
SPDR S&P Biotech ETF
XBI
|
+$799M |
| 4 |
Industrial Select Sector SPDR Fund
XLI
|
+$793M |
| 5 |
GE Aerospace
GE
|
+$748M |
Top Sells
| 1 |
Tesla
TSLA
|
+$362M |
| 2 |
Utilities Select Sector SPDR Fund
XLU
|
+$345M |
| 3 |
NVIDIA
NVDA
|
+$258M |
| 4 |
MetLife
MET
|
+$257M |
| 5 |
Meta Platforms (Facebook)
META
|
+$223M |
Sector Composition
| 1 | Technology | 26.74% |
| 2 | Consumer Discretionary | 11.23% |
| 3 | Financials | 10.63% |
| 4 | Healthcare | 8.41% |
| 5 | Communication Services | 8.06% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
3326
Granite Ridge Resources
GRNT
$705M
| $62.1K | ﹤0.01% |
+9,619
| New | +$62.1K |
|
3327
OmniAb
OABI
$236M
| $62.1K | ﹤0.01% |
+17,549
| New | +$62.1K |
|
3328
Portillo's
PTLO
$441M
| $62K | ﹤0.01% |
+6,594
| New | +$62K |
|
3329
Jasper Therapeutics
JSPR
$39.5M
| $61.7K | ﹤0.01% |
2,888
+376
| +15% | +$8.04K |
|
|
INVX
3330
Innovex International, Inc.
INVX
$1.14B
| $61.6K | ﹤0.01% |
4,406
-53,421
| -92% | -$746K |
|
3331
Standard BioTools
LAB
$493M
| $61.3K | ﹤0.01% |
35,004
-60,002
| -63% | -$105K |
|
3332
Foghorn Therapeutics
FHTX
$293M
| $61.1K | ﹤0.01% |
+12,946
| New | +$61.1K |
|
3333
Potbelly
PBPB
$514M
| $61K | ﹤0.01% |
6,473
-28,505
| -81% | -$269K |
|
3334
American Realty Investors
ARL
$256M
| $61K | ﹤0.01% |
4,152
-712
| -15% | -$10.5K |
|
3335
Erasca
ERAS
$443M
| $60.8K | ﹤0.01% |
+24,225
| New | +$60.8K |
|
3336
Movado Group
MOV
$438M
| $60.8K | ﹤0.01% |
3,087
-2,490
| -45% | -$49K |
|
3337
Five Star Bancorp
FSBC
$701M
| $60.2K | ﹤0.01% |
+1,999
| New | +$60.2K |
|
3338
Central Garden & Pet
CENT
$2.24B
| $60.1K | ﹤0.01% |
1,550
-7,510
| -83% | -$291K |
|
3339
Tyra Biosciences
TYRA
$667M
| $60K | ﹤0.01% |
+4,318
| New | +$60K |
|
3340
Blackstone Secured Lending
BXSL
$6.58B
| $60K | ﹤0.01% |
+1,857
| New | +$60K |
|
3341
Greenland Technologies Holding Corp
GTEC
$23.3M
| $59.8K | ﹤0.01% |
+30,812
| New | +$59.8K |
|
3342
Atlanta Braves Holdings Series A
BATRA
$2.86B
| $59.2K | ﹤0.01% |
+1,451
| New | +$59.2K |
|
3343
Flexsteel Industries
FLXS
$258M
| $58.9K | ﹤0.01% |
1,083
-8,448
| -89% | -$459K |
|
3344
Altimmune
ALT
$321M
| $58.8K | ﹤0.01% |
8,156
-33,984
| -81% | -$245K |
|
3345
Dianthus Therapeutics
DNTH
$1.2B
| $58.8K | ﹤0.01% |
+2,695
| New | +$58.8K |
|
3346
Instil Bio
TIL
$163M
| $58.7K | ﹤0.01% |
3,076
+3,011
| +4,632% | +$57.5K |
|
3347
ING
ING
$74.7B
| $58.7K | ﹤0.01% |
3,746
-46,378
| -93% | -$727K |
|
3348
Prime Medicine
PRME
$726M
| $58.7K | ﹤0.01% |
+20,096
| New | +$58.7K |
|
3349
US Global Jets ETF
JETS
$824M
| $58.7K | ﹤0.01% |
2,314
-40,849
| -95% | -$1.04M |
|
3350
Annexon
ANNX
$266M
| $58.5K | ﹤0.01% |
+11,404
| New | +$58.5K |
|